#United States #New Orleans #Diabetes Technology #MiniMed #MiniMed Flex

MiniMed Showcases the Future of Diabetes Management

In an exciting announcement, MiniMed (Nasdaq: MMED), a leading company in diabetes technology, has revealed its plans to participate in the upcoming American Diabetes Association (ADA) Scientific Sessions, scheduled for June 5-8 in New Orleans. This event holds special significance as it marks MiniMed's inaugural U.S. diabetes congress since its transition into a standalone public entity. The company will showcase their latest technological advancements designed to provide individuals with diabetes greater freedom and control over their health.

A Focus on Empowerment and Innovation

MiniMed is committed to alleviating the everyday challenges faced by those living with diabetes. At the heart of their display will be innovative products such as the highly anticipated MiniMed Flex™, a screenless, smartphone-operated pump featuring SmartGuard™ automation, alongside the MiniMed Go™, an intelligent insulin pen that offers users reminders, recommendations, and tracking capabilities. Both products represent a new generation of devices aiming to revolutionize diabetes management.

Hands-On Demonstrations and Clinical Insights

Attendees will have opportunities for hands-on interactions with these cutting-edge systems. MiniMed plans to present emerging clinical data that underscores the efficacy of these products, including insights gained from their recently updated sensor portfolio. The aim is to provide not only a preview of their technology but also concrete evidence of improved management outcomes for diabetes patients.

Engaging Sessions and Educational Opportunities

The program will include several engaging sessions with industry-leading experts. On June 6, MiniMed will host a product theater session titled "MiniMed Introducing New Insulin Delivery Systems" featuring experts like Dr. Anuj Bhargava, CEO and Medical Director at Iowa Diabetes. Additionally, Dr. Robert Vigersky, the Vice President and Chief Medical Officer of MiniMed, will present a learning byte on June 7 about making both days and nights better for individuals with diabetes.

Scientific Presentations

In addition to the product showcases and demonstrations, MiniMed will present various scientific posters highlighting independent research and findings related to their devices. For instance, topics will include the expansion of automated insulin delivery in diverse populations and the long-term effectiveness of the MiniMed™ 780G system, particularly among users managing both type 1 and type 2 diabetes.

This year's ADA Scientific Sessions will provide a platform for demonstrating MiniMed's unyielding dedication to improving diabetes care through technology. By incorporating advanced automation and user-friendly designs, MiniMed aims to not only enhance clinical outcomes but also ensure a better quality of life for those affected by diabetes.

Looking Ahead

This event not only showcases the latest advancements in diabetes management technology but also represents MiniMed's continuous commitment to innovation and patient care. With a robust portfolio aimed at creating seamless and effective care experiences, MiniMed is poised to lead the charge in transforming diabetes therapy. The ongoing evolution of their products reflects an unwavering focus on their mission: improving everyday life for individuals managing diabetes across the globe.

As the conference approaches, excitement builds around what MiniMed will unveil next. Whether you are a healthcare professional or a patient looking for new ways to manage diabetes, the ADA Scientific Sessions promise valuable insights and groundbreaking innovations in diabetes technology.